JERUSALEM--(BUSINESS WIRE)--May 25, 2006--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA - News) announced today that the U.S. Food and Drug Administration (“FDA”) has granted tentative approval for the Company’s Ivax Abbreviated New Drug Application (“ANDA”) for Simvastatin Tablets USP, 5 mg, 10 mg, 20 mg, 40 mg and 80 mg.
